GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Zynex Inc (NAS:ZYXI) » Definitions » Shiller PE Ratio

Zynex (ZYXI) Shiller PE Ratio : (As of May. 08, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Zynex Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Zynex Shiller PE Ratio Historical Data

The historical data trend for Zynex's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zynex Shiller PE Ratio Chart

Zynex Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 188.29 203.60 90.27 95.81 53.48

Zynex Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 78.53 56.20 43.36 53.48 -

Competitive Comparison of Zynex's Shiller PE Ratio

For the Medical Distribution subindustry, Zynex's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zynex's Shiller PE Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Zynex's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Zynex's Shiller PE Ratio falls into.



Zynex Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Zynex's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Zynex's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0/129.4194*129.4194
=0.000

Current CPI (Mar. 2024) = 129.4194.

Zynex Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -0.164 100.560 -0.211
201409 0.009 100.428 0.012
201412 0.018 99.070 0.024
201503 -0.027 99.621 -0.035
201506 -0.018 100.684 -0.023
201509 -0.009 100.392 -0.012
201512 -0.036 99.792 -0.047
201603 -0.009 100.470 -0.012
201606 -0.009 101.688 -0.011
201609 0.018 101.861 0.023
201612 0.006 101.863 0.008
201703 0.009 102.862 0.011
201706 0.045 103.349 0.056
201709 0.064 104.136 0.080
201712 0.091 104.011 0.113
201803 0.055 105.290 0.068
201806 0.064 106.317 0.078
201809 0.073 106.507 0.089
201812 0.073 105.998 0.089
201903 0.064 107.251 0.077
201906 0.055 108.070 0.066
201909 0.055 108.329 0.066
201912 0.082 108.420 0.098
202003 0.082 108.902 0.097
202006 0.082 108.767 0.098
202009 0.036 109.815 0.042
202012 0.040 109.897 0.047
202103 -0.020 111.754 -0.023
202106 0.070 114.631 0.079
202109 0.160 115.734 0.179
202112 0.230 117.630 0.253
202203 0.030 121.301 0.032
202206 0.080 125.017 0.083
202209 0.130 125.227 0.134
202212 0.200 125.222 0.207
202303 0.040 127.348 0.041
202306 0.090 128.729 0.090
202309 0.100 129.860 0.100
202312 0.030 129.419 0.030
202403 0.000 129.419 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Zynex  (NAS:ZYXI) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Zynex Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Zynex's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Zynex (ZYXI) Business Description

Traded in Other Exchanges
N/A
Address
9555 Maroon Circle, Englewood, CO, USA, 80112
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufacture, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. it also develops and markets medical devices for non-invasive cardiac monitoring, the products of which are under development. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave and others.
Executives
Daniel J Moorhead officer: Chief Financial Officer 9777 PYRAMID CT, STE 100, ENGLEWOOD CO 80112
Anna Lucsok officer: See Remarks 9555 MAROON CIRCLE, ENGLEWOOD CO 80112
Thomas Sandgaard director, 10 percent owner, officer: President, CEO and Chairman 10506 KALAHARI CT., LONE TREE CO 80124
Neil Friery officer: See Remarks C/O ZYNEX, INC. 9555 MAROON CIRCLE, ENGLEWOOD CO 80112
Joshua R. Disbrow director AMPIO PHARMACEUTICALS, INC., 5445 DTC PARKWAY, SUITE 925, GREENWOOD VILLAGE CO 80111
Barry D Michaels director 6275 NANCY RIDGE DRIVE, SUITE 110, SAN DIEGO CA 92121
Michael D Cress director 3409 ESPERANZA CROSSING SUITE 7110, AUSTIN TX 78758
Sandgaard Holdings Llc 10 percent owner 9555 MAROON CIRCLE, ENGLEWOOD CO 80112
Giuseppe Papandrea officer: Chief Operating Officer C/O ZYNEX, INC. 9555 MAROON CIRCLE, ENGLEWOOD CO 80112